Elevating CKD-aP Care: New Frontier
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
CKD-aP: Beyond the Surface
Leonie Kraft, MD
Quantifying CKD-aP: Tools for Better Care
Emilio Sanchez, MD, PhD
CKD-aP Treatment Tool Kit
Kappa-Opioid Settings: Real-World Evidence Insights
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
The Critical Interplay: CKD, HF, and HyperkaleAmia
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Javed Butler, MD, MPH, MBA
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Potassium Binders in Practice: Clinical Trial Evidence
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Future Directions in Managing Hyperkalemia in CKD and HF
Potassium Binders: Safety Comes First!
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.